Article | February 6, 2024

Constraints And Solutions For Biopharmaceutical Manufacturing

By Scott Merz, Sales Manager – The Americas

Engineers In Lab GettyImages-1217882746

Biopharmaceutical manufacturing is facing capacity bottlenecks due to process development, downstream chromatography, and equipment constraints. Delays in process development can lead to market competition, resource burdens, and outdated technology. Downstream processing, particularly chromatography, is a bottleneck due to complexity and resource requirements, and equipment constraints and maintenance issues also impact capacity. High costs and limited adaptability hinder scaling up production.

Solutions such as parallel development, advanced software, and AI can increase capacity and streamline processes. Investing in automation and robotics can improve efficiency and product quality. Standardization, modular designs, and reliable suppliers can enhance flexibility and consistency. Predictive maintenance strategies can prevent unexpected downtime. Addressing these bottlenecks is crucial for a consistent supply of life-saving therapies.

This article dives into more detail on the reasons for critical capacity bottlenecks and the challenges and potential solutions associated with each.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online